Honokiol attenuate the arsenic trioxide‐induced cardiotoxicity by reducing the myocardial apoptosis

Despite advantages of arsenic trioxide (ATO) in oncological practice, its clinical applications have been hampered by severe cardiotoxicity. The general mechanism of ATO‐induced cardiotoxicity has been attributed to its damage to mitochondria, resulting in cardiac remodeling. Honokiol (HKL) is a nat...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, An‐Liang, Yang, Fan, Cheng, Ping, Liao, Dian‐ying, Zhou, Li, Ji, Xing‐Li, Peng, Dou‐Dou, Zhang, Li, Cheng, Ting‐Ting, Ma, Li, Xia, Xian‐Gen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848632/
https://www.ncbi.nlm.nih.gov/pubmed/35171536
http://dx.doi.org/10.1002/prp2.914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848632/
https://www.ncbi.nlm.nih.gov/pubmed/35171536
http://dx.doi.org/10.1002/prp2.914

Ejemplares similares